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Abstract
Background:  D o w n ' s  s y n d r o m e  ( D S )  i s  characterized by several immunological defects, especially regarding T cell
compartment. DS is considered the best example of accelerated ageing in humans. Direct observations of the thymus have
shown that in DS this organ undergoes severe histological and morphological changes. However, no data on its capacity to
generate T cells are present in the literature. Here, using a new technology based upon real time PCR, we have investigated the
capacity of the thymus to produce and release newly generated T lymphocytes (the so called "recent thymic emigrants", RTE)
in children with DS.
Methods: We studied 8 children affected by DS, aged 2–7 years, compared with 8 age- and sex-matched healthy controls. Flow
cytometry was used to determine different lymphocytes subsets. Real time PCR with the Taqman system was used to quantify
the amount of RTE, i.e. peripheral blood lymphocytes that express the T cell receptor rearrangement excision circles (TREC).
Results: In comparison with control children, those with DS had a significant lower number of TREC+ peripheral blood cells.
Moreover, in DS children but not in controls, a strong negative correlation between age and the levels of TREC+ cells was found.
Conclusions: The direct measure of thymic output indicates that the impairment of the organ results in a reduced production
of newly generated T cells. This observation could suggest that cytokines able to modulate thymic function, such as interleukins,
could be useful to improve the functionality of the organ and to treat the immunodeficiency present in DS subjects.
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Introduction
Down's Syndrome (DS) is the most common chromo-
somal abnormality in humans, that occurs in 1 out of
every 800–1,000 births. It is an autosomal disorder result-
ing by triplication of chromosome 21. Many characteris-
tics are commonly seen in DS, including some degree of
intellectual impairment, that varies widely from individ-
ual to individual, heart defects, hypotonia, hyperuri-
cemia, and the development of Alzheimer disease-type
neuropathology beginning at about 40 years of age [1].
DS subjects also present alterations of the immune system
which are similar to those of aged people, including
increased susceptibility to bacterial and viral infection and
to the onset of different types of haematological malig-
nancies, along with a high frequency of autoantibodies.
Alterations of B lymphocytes, T cell subsets, and natural
killer cells, defective phagocytosis and chemotaxis of pol-
ymorphonuclear leukocytes and interleukin-2 production
by activated T cells were also reported [2-7]. Quantitative
studies of peripheral blood T lymphocytes reveal a reduc-
tion, often quite small, in the percentage and/or absolute
number of T lymphocytes, although normal proportions
or numbers of T and B lymphocytes in DS children have
also been reported [8].
Several studies have focused their attention on the role of
the thymus, and have described a variety of structural and
anatomic alterations present in DS [9]. Few data, if any,
exist on the direct measure of thymic functionality in
terms of production of newly generated T cells. Accord-
ingly, the aim of this study was to measure the capability
of the thymus of DS children to produce new T lym-
phocytes, and to analyze how such capability changes
with age. For this reason, we have quantified the so called
"recent thymic emigrants" (RTE), that are the main con-
tributors to the naïve T-cell pool, and are characterized by
the presence in the nucleus of a circular, episomal DNA
molecule called TREC (T cell receptor Rearrangement
Excision Circles), generated during the intrathymic rear-
rangement of the α-chain locus of the T cell receptor
(TCR).
Genes for the δ-chain of the TCR are distributed within the
genomic region that codifies for the α-chain, and are
removed in two steps during the recombination of Vα
with Jα. Thus, a thymocyte that starts to rearrange the α-
chain produces the first TREC, called signal-joint (sj)-
TREC, then proliferates three or four times, and finally
completes the rearrangement of Vα with Jα, so producing
the second TREC, called coding-joint (cj)-TREC. The
removal of genes for the δ-chain from the α region does
not imply their elimination, as such DNA remains into
the nucleus as a circle that is not able to replicate. As a con-
sequence, when a cell undergoes a division, TREC are
passed only to one of the two daughter cells. During the
following cell cycles, TREC are then diluted into the pop-
ulation that origins from the first cell. Several data indi-
cated that the percentage of TREC+ cells is a marker of
thymic activity, that TREC+ cells are almost present within
the subset of virgin T lymphocytes, and that their number
consistently declines with age [10].
Materials and Methods
Subjects
We could analyze blood samples from 8 children with DS
(with a mean age of 4.62 years, range: 2–7 years), 7 males
and 1 females. As control group, we studied 8 children
with a mean age of 4.75 years (range, 2–8 years), 7 males
and 1 female. All subjects were in good conditions, and
had no acute or chronic disease affecting the immune sys-
tem. Written informed consent was obtained by their par-
ents, according to the Italian laws.
Isolation of PBMC from blood
Peripheral blood mononuclear cells (PBMC) were sepa-
rated from a minimum of 8 mL freshly collected blood
according to standard procedures.
Analysis of the phenotype of peripheral blood lymphocytes
Blood samples were stained with different monoclonal
antibodies for the cytometric analysis, as described [11].
The quantification of the main subpopulations present
among lymphocytes (electronically selected on the basis
of an electronic gate put in the region of lymphocytes) was
performed by flow cytometry using a CyFlow ML instru-
ment (Partec, Münster, Germany), according to standard
procedures [11].
DNA extraction
DNA was extracted from 5 × 106 PBMC using the QIAamp
DNA Mini Kit (QIAGEN) according to the manufacturer's
protocols and stored in sterile water at -20°C until use.
Quantification of percentage of sjTREC positive PBMC by 
a Real Time PCR approach
The percentage of PBMC containing sjTREC was measured
by an original method that has been recently developed
(patent pending) using a Real Time PCR approach. This
assay was performed by two parallel polymerase chain
reactions (PCR), that quantify sjTREC or nuclear DNA
(nDNA) in a given sample, carried out in two different
reaction tubes, but in the same plate, in order to have sim-
ilar reaction conditions.
In the first reaction, we quantified sjTREC using a mix that
consisted of: Supermix Biorad 1X, primers for sjTREC 500
pmol and we added 3 µl of the sample in each tube. The
sjTREC primers we used were: sjTREC Dir (5'-CAC ATC
CCT TTC AAC CAT GCT-3') and sjTREC Rev (5'-GCC AGCImmunity & Ageing 2005, 2:4 http://www.immunityageing.com/content/2/1/4
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TGC AGG GTT TAG G-3'). TaqMan probe for sjTREC (5'-
FAM-ACA CCT CTG GTT TTT GTA AAG GTG CCC ACT –
BLACK HOLE-3') was included in the reaction mixture at
the concentration of 200 nM, as a real time detector for
the amplified product. One cycle of denaturation (95°C
for 6 min) was performed, followed by 50 cycles of ampli-
fication (95°C for 30 sec, 58°C for 1 min 30 sec). The
same approach was used to quantify nDNA, which was
required to obtain the number of cells present in the sam-
ple. In this case, primers GenDir (5'-GGC TCT GTG AGG
GAT ATA AAG ACA-3') and GenRev (5'-CCA ACC ACC
CGA GCA ACT AAT CT-3'), designed on FasL gene
sequence, present in two copies in the human genome
(one in each chromosome 1), were used at the concentra-
tion of 600 and 400 nM respectively, and the TaqMan
probe GenProbe (5' TexasRed – CTG TTC CGT TTC CTG
CCG GTG C – BlackHole Quencher2 3') was included in
the reaction mixture at the concentration of 300 nM. One
cycle of denaturation (95°C for 3 min 30 sec) was per-
formed, followed by 45 cycles of amplification (95°C for
30 sec, 60°C for 35 sec).
All of the aforementioned primers and probes have been
designed using the program "primer3", available on the
internet address: http://www.genome.wi.mit.edu/cgi-bin/
primer/primer3.cgi. The length of amplified fragments is
104 pb for nDNA and 101 pb for sjTREC.
PCR was performed by using an iCycler Thermal cycler
(BioRad, Hercules, CA, USA), that monitors changes in
the fluorescence spectrum of each reaction tube during
the annealing phase. The fluorescence signal was proc-
essed using the "Real-time detection system iCycler iQ"
software, that calculates the threshold and the threshold
cycles of each sample. All reactions were carried out in
triplicate.
To optimize the precision of the assay, whose results
derive from the comparison between the threshold cycles
of two different real time PCR reactions, we have devel-
oped a new approach. Indeed, the regions used as tem-
plate for the two amplifications (i.e., those of sjTREC and
nDNA) were purified and cloned tail to tail in a vector
(pGEM-11Z, from Promega), to have a ratio of 1:1 of the
molecules used as reference.
The nDNA region used has been excised as a SacI-ApaI
fragment and cloned in the pGEMT easy vector
(Promega), obtaining the pGEM11Z-nDNA vector. The
sjTREC region used has been excised as a PstI-SacI frag-
ment and cloned in the same vector, obtaining the pSJ
vector we used. The plasmid has been purified, quantified
with the spetrofotometer and linearized using SacI. Then
a series of reactions has been performed for nDNA and
sjTREC with serial dilution of the standard. All the times
the threshold cycles of nDNA and sjTREC were the same,
proving the ratio 1:1 of the two fragments.
Then, serial known dilutions of this vector, amplified in
triplicate, were included in each PCR run to generate a
standard curve from which the relative copy number of
either sjTREC or nDNA present in the unknown samples
was determined. The measured values for sjTREC and
nDNA were always within the range of the standard curve,
whose correlation coefficient was always >0.990. The val-
ues of sjTREC and nDNA present in each sample were cal-
culated using the mean of the threshold cycles of the three
replicates.
Then, the percentage of PBMC containing sjTREC in each
sample was simply obtained from the ratio between the
relative values of sjTREC (obtained dividing for 3 the
result given by the iCycler, as we used 3 µl of DNA of the
sample and 1 µl of standard to quantify sjTREC) and
nDNA obtained (obtained versus the same vector), multi-
plied by 2 (as two copies of the nuclear gene are present
in a cell).
Results
Peripheral blood cell phenotype in DS
Down's syndrome is characterized by severe immunolog-
ical alterations, which mainly affect the T cell compart-
ment and are often regarded as signs of accelerated ageing.
Numerous reports suggested that thymic retention of T
cells or maturation defects might be the cause of the
observed alterations in the T cell compartment. Accord-
ingly, we first checked the presence of possible changes in
the phenotype of peripheral blood lymphocytes from DS
children. As shown in Figure 1, we found that, in compar-
ison with karyotypically normal healthy controls, DS chil-
dren had less T helper cells and more cytotoxic T
lymphocytes or cells expressing markers related to NK
activity. This indicates that the population we analyzed
can well represent the immunological situation present in
DS children.
Quantitative analysis of cells expressing TREC
We then studied directly the capacity of the thymus to pro-
duce new T lymphocytes, by the analysis of TREC+ cells.
Figure 2 shows a typical example of real time PCR assay
for quantification of the amount of TREC per cell. It is to
note that the threshold cycle, i.e. the cycle of PCR in which
the fluorescent signal deriving from the amplification of
the DNA becomes evident, is quite different in DS chil-
dren and controls. Indeed, such cycle is much lower in
control children, indicating the presence of a higher
number of TREC.Immunity & Ageing 2005, 2:4 http://www.immunityageing.com/content/2/1/4
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The percentage of TREC+ lymphocytes in children affected
by Down's syndrome and in controls is reported in Figure
3. A statistically significant difference was present between
the two groups (p = 0.007), indicating that DS is charac-
terized by a lower thymic output.
Correlation between age and TREC
Finally, we have investigated the correlation between age
and TREC levels in the two groups. As reported in Figure
4, it is noteworthy that while control children did not dis-
play any age-related change (in the age range 2–8 years),
those with DS had a significant age-related decrease in the
number of TREC+ cells. This indicates that in DS, in con-
trast with control children, major changes in thymic out-
put occur in the very first years of life.
Discussion
Immunological ageing is part of a continuum of develop-
mental processes, encompassing complex reorganiza-
tional events, compensatory mechanisms and qualitative
alterations in the functionality of several systems and
organs. Among those organs that undergo major changes
with ageing, thymus plays a special role [12]. The thymus
is a central lymphoid organ that is the primary site of T-
cell maturation and development. Shortly after birth, the
thymus undergoes a life long process of involution
whereby the organ is replaced by adipose tissue. The result
Phenotypic analysis of peripheral blood lymphocytes in patients with Down's syndrome (DS) and healthy subjects Figure 1
Phenotypic analysis of peripheral blood lymphocytes in patients with Down's syndrome (DS) and healthy subjects. Data are 
referred to 8 individuals per group. Asterisk indicates a statistically significant difference (p < 0.05).
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is a reduction in the number of constituent thymocytes
with age, a consequent shrinking of the thymus and a
decline in the output of newly generated T lymphocytes
[13].
Aged peripheral T-cell pool is characterized by the accu-
mulation of T-cell capable of limited replication [14].
Since an efficient immune response is based upon the
expansion of antigen-specific clones, the consequence of
a qualitative and quantitative impairment of the system is
an increased susceptibility to infections or cancer. Several
groups, including ours, have studied the immune system
during human ageing, using different models, including
the one that represents the best example of successful age-
ing, i.e. healthy centenarians, and conditions of acceler-
ated ageing, such as DS [2-6,15].
In DS subjects, the proportion of T-helper cells is
decreased, resulting in a decreased ratio of helper/cyto-
toxic cells, and we could observe this phenomenon also in
the patients here described. Furthermore, peripheral
blood T cells have a decreased number of cells expressing
the T-cell receptor-αβ (TCRαβ) complex, elevated num-
bers expressing TCRγδ and a decreased proportion of
CD4+, CD45RA+ naïve T cells, along with a high number
of cells with NK phenotype, suggesting that the DS thy-
mus is inefficient in the release of functionally mature T
cells [16]. An age-dependence in the proliferative
response to phytohemagglutinin (PHA) of DS lym-
phocytes, but not of lymphocytes from healthy individu-
als, was observed. Allogeneic mixed lymphocyte
proliferative responses are decreased, as are PHA-induced
interleukin-2 production and cytotoxic T-lymphocyte
activity [7].
Representative example of real time PCR for the quantification of TREC in a group of 3 children with Down's syndrome (DS)  and in 4 healthy controls (each measure is performed in triplicate) Figure 2
Representative example of real time PCR for the quantification of TREC in a group of 3 children with Down's syndrome (DS) 
and in 4 healthy controls (each measure is performed in triplicate). Note how the threshold cycle is different in the two 
groups.
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All of the above mentioned alterations have a common
substrate, i.e. the dysfunction of thymus. Indeed, defects
in the capacity to produce thymic hormones has been
described several years ago [17,18]. Furthermore, ana-
tomic studies gave further evidence that changes in the T-
lymphocyte system derive from structural abnormalities
of the thymus. In comparison to age-matched controls,
thymuses from infants with DS from 1 day to 15 months
of age have marked lymphoid depletion, with a thin cor-
tex and poor corticomedullary demarcation. The Hassall
corpuscles are increased in size and frequently cystic. The
presence of lower proportions of cells bearing high levels
of the TCR-αβ complex and of CD3, a signal-transducing
complex for the TCR, in thymuses of children with DS and
the increase in the proportions of cells with these markers
with age are indicative of delayed maturation of T cells
within the thymus [9]. In addition, DS thymuses contain
elevated levels of IFN-γ and TNF-α mRNA expressing cells,
and there is mast cell hyperplasia and overexpression of
class I MHC, CD18 and ICAM-1 [19]. DS thymocytes also
have a greater than normal sensitivity to inhibition of IL-
4-induced proliferation by IFN-γ and TNF-α [20]. Taken
together, these findings indicate an abnormal thymocyte
maturation and cytokine dysregulation in the DS thymus,
possibly initiated by gene dose-related increased sensitiv-
ity to IFN-γ and to overexpression of CD18 (LFA-1β).
DS children have less TREC+ lymphocytes than healthy controls, as shown in this box-and-whiskers graphics Figure 3
DS children have less TREC+ lymphocytes than healthy controls, as shown in this box-and-whiskers graphics. The boxes 
extend from the 25th percentile (x[25]) to the 75th percentile (x[75]) [i.e., the interquartile range (IQ)]; lines inside boxes repre-
sent median values. Lines emerging from boxes (i.e., the whiskers) extend to the upper and lower adjacent values. The upper 
adjacent value is defined as the largest data point ≤x[75]+1.5xIQ, and the lower adjacent value is defined as the smallest data 
point ≥x[25]-1.5xIQ. Note that no outliers are present in the two groups.
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In conclusion, in this paper we show that the aforemen-
tioned alterations of the thymus result in the reduced
production and output of newly generated lymphocytes,
that can be directly measured by the assay we have devel-
oped and used. The quantitative analysis of TREC+ cells in
the periphery is a relatively new and sensitive marker of
thymic functionality, which is able to provide informa-
tion on the status of the organ in different pathological
conditions, and on its capability to generate new T cells
[21-25]. A markedly reduced capacity of the thymus to
produce RTE is present in the DS children we have stud-
ied. Such observation, if confirmed in a higher number of
cases, could be useful to develop novel strategies to treat
the immunodeficiency typical of this syndrome, based for
example on the use of cytokines such as interleukin-2 or
interleukin-7, which is capable of maintaining or restor-
ing an efficient thymic output [26].
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